Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Patton John Stuart
Relationship:   Chief Scientific Offic...
City:   San Diego,
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   493,756    

Indirect Shares

  233,444      
Direct Value   $8,730,050    

Indirect Value

  $10,590,183      
Total Shares   727,200      
Total Value   $19,320,233      


Halozyme Therapeutics Inc
 $8,180,760 Nektar Therapeutics
 $549,290 Halozyme Therapeutics Inc
 $8,180,760 Nektar Therapeutics
 $549,290
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Halozyme Therapeutics Inc HALO Director 2014-08-19 179,876 2005-01-18 232,830    Premium*  
            Nektar Therapeutics NKTR Chief Scientific Offic... 2008-11-14 313,880 2006-05-15 614    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
NKTR Nektar Therapeutics officerTitle   •       •      –    2006-01-19 4 OE $19.37 $452,386 I/I 23,355 571,657 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2006-03-03 4 A $0.01 $103 I/I 10,333 561,990 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2006-03-07 4 S $19.80 $76,390 I/I (3,859) 558,131 -
NKTR Nektar Therapeutics officerTitle   •       •      –    2006-01-27 4 AS $22.00 $440,000 I/I (20,000) 551,657 -
NKTR Nektar Therapeutics officerTitle   •       •      –    2006-01-18 4 OE $19.32 $669,341 I/I 34,645 548,302 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2004-01-13 4 AS $18.18 $363,733 I/I (20,000) 547,308 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2005-03-14 4 A $0.00 $0 I/I 4,166 539,044 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2005-01-14 4 OE $18.61 $588,076 I/I 31,600 534,878 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2005-03-14 4 S $14.37 $21,368 I/I (1,487) 534,878 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2004-02-10 4 AS $20.00 $400,000 I/I (20,000) 527,308 -
NKTR Nektar Therapeutics officerTitle   •       •      –    2006-01-13 4 AS $20.00 $400,716 I/I (20,000) 513,657 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2004-03-04 4 AS $22.00 $443,522 I/I (20,000) 507,308 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2004-12-16 4 GD $0.00 $0 I/I 4,030 503,278 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-03-14 4 AS $8.00 $131,397 D/D (16,400) 346,071 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-03-15 4 AS $8.00 $68,800 D/D (8,600) 337,471 0 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2007-03-09 4 A $0.01 $150 D/D 15,001 328,542 0 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2008-11-14 4 OE $0.00 $0 D/D 2,500 314,640 0 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2008-11-14 4 S $4.37 $3,321 D/D (760) 313,880 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-03-21 4 AS $8.50 $214,870 D/D (25,000) 312,471 0 -
NKTR Nektar Therapeutics Chief Scientific Officer   •       •      –    2007-05-14 4 A $0.01 $30 D/D 3,000 311,864 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-03-28 4/A AS $8.30 $209,979 D/D (25,000) 287,471 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-04-04 4 AS $8.30 $208,916 D/D (25,000) 262,471 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2014-08-19 4 OE $2.05 $153,750 D/D 75,000 254,876 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-05-15 4 A $10.37 $155,550 D/D 15,000 252,171 0 -
HALO Halozyme Therapeutics Inc Director   –       •      –    2007-04-11 4 AS $8.46 $215,390 D/D (25,000) 237,471 0 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed